VCIM
NSRX

Velan Capital Investment Management’s Nasus Pharma NSRX Stock Holding History

Velan Capital Investment Management’s Portfolio NSRX Stock Details NSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$798K Buy
+359,390
New +$1.86M 0.5% 26

Other funds holding NSRX

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Velan Capital Investment Management's NSRX Position: Q1 2026 in Review

Velan Capital Investment Management opened a new position in Nasus Pharma (NSRX) in Q1 2026: 359,390 shares worth $798K. The stake represents 0.5% of the portfolio and ranks #26 among its holdings.

9 funds tracked by Wall St. Rank hold NSRX as of Q1 2026.

  • Velan Capital Investment Management held 359,390 shares of Nasus Pharma worth $798K as of Q1 2026.
  • Nasus Pharma was a new Velan Capital Investment Management position in Q1 2026.
  • Nasus Pharma made up 0.5% of Velan Capital Investment Management's portfolio in Q1 2026, its #26 holding.
  • 9 funds tracked by Wall St. Rank held Nasus Pharma as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.